• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国痴呆症专科医生短缺的地理差异。

Geographic variation in shortfalls of dementia specialists in the United States.

作者信息

Liu Jodi L, Baker Lawrence, Chen Annie Yu-An, Wang Jue Jessie

机构信息

RAND, Economics, Sociology, and Statistics Department, Santa Monica, CA 90407-2138, USA.

RAND, Pardee RAND Graduate School, Santa Monica, CA 90407-2138, USA.

出版信息

Health Aff Sch. 2024 Jul 18;2(7):qxae088. doi: 10.1093/haschl/qxae088. eCollection 2024 Jul.

DOI:10.1093/haschl/qxae088
PMID:39081720
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11288326/
Abstract

Dementia specialists-neurologists, geriatricians, and geriatric psychiatrists-serve a critical clinical function in diagnosing early-stage Alzheimer's disease and determining eligibility for treatment with disease-modifying therapies. However, the availability of dementia specialists is limited and varies across the United States. Using data from the Area Health Resources Files, we found that the median density of dementia specialists across hospital referral regions in United States is 28.8 per 100 000 population aged 65 years and older (interquartile range 19.3-43.6). We derived thresholds of 33-45 dementia specialists per 100 000 population aged 65 years and older as the provider density necessary to care for older adults with mild cognitive impairment and dementia. Based on these thresholds, we estimated that 34%-59% of the population aged 65 years and older resided in areas with potential dementia specialist shortfalls. The extent of potential shortfalls varied by state and rurality. A better understanding of potential gaps in the availability of dementia specialists will inform policies and practices to ensure access to services for people with cognitive impairment and dementia.

摘要

痴呆症专科医生(神经科医生、老年病科医生和老年精神科医生)在诊断早期阿尔茨海默病以及确定使用疾病修正疗法进行治疗的资格方面发挥着关键的临床作用。然而,痴呆症专科医生的数量有限,且在美国各地存在差异。利用地区卫生资源档案的数据,我们发现美国各医院转诊地区痴呆症专科医生的中位数密度为每10万65岁及以上人口中有28.8名(四分位距为19.3 - 43.6)。我们得出每10万65岁及以上人口中有33 - 45名痴呆症专科医生的阈值,作为照顾轻度认知障碍和痴呆症老年人所需的医疗服务提供者密度。基于这些阈值,我们估计65岁及以上人口中有34% - 59%居住在痴呆症专科医生可能短缺的地区。潜在短缺的程度因州和农村地区而异。更好地了解痴呆症专科医生可及性方面的潜在差距,将为政策和实践提供信息,以确保认知障碍和痴呆症患者能够获得服务。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/654b/11288326/e872d8579299/qxae088f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/654b/11288326/e872d8579299/qxae088f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/654b/11288326/e872d8579299/qxae088f1.jpg

相似文献

1
Geographic variation in shortfalls of dementia specialists in the United States.美国痴呆症专科医生短缺的地理差异。
Health Aff Sch. 2024 Jul 18;2(7):qxae088. doi: 10.1093/haschl/qxae088. eCollection 2024 Jul.
2
Understanding the role of psychiatrists in the diagnosis and management of mild cognitive impairment and mild Alzheimer's disease dementia: a cross-sectional survey.理解精神科医生在轻度认知障碍和轻度阿尔茨海默病痴呆症的诊断和管理中的作用:一项横断面调查。
BMC Psychiatry. 2023 Oct 4;23(1):716. doi: 10.1186/s12888-023-05129-5.
3
2024 Alzheimer's disease facts and figures.2024 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2024 May;20(5):3708-3821. doi: 10.1002/alz.13809. Epub 2024 Apr 30.
4
2023 Alzheimer's disease facts and figures.2023 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2023 Apr;19(4):1598-1695. doi: 10.1002/alz.13016. Epub 2023 Mar 14.
5
6
7
Specialist Availability and Drug Adherence in Older Adults with Dementia Across Regions of the United States.美国不同地区老年痴呆症患者的专科医生可及性和药物依从性。
J Alzheimers Dis. 2023;93(3):927-937. doi: 10.3233/JAD-220620.
8
9
2022 Alzheimer's disease facts and figures.2022 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2022 Apr;18(4):700-789. doi: 10.1002/alz.12638. Epub 2022 Mar 14.
10
Dementia Care in Diverse Older Adults in the U.S. Deep South and the Rest of the United States.美国南部和美国其他地区不同老年人群的痴呆症护理。
J Alzheimers Dis. 2021;83(4):1753-1765. doi: 10.3233/JAD-210240.

引用本文的文献

1
Accurate deep-learning model to differentiate dementia severity and diagnosis using a portable electroencephalography device.使用便携式脑电图设备区分痴呆严重程度和诊断的精确深度学习模型。
Sci Rep. 2025 Jul 20;15(1):26304. doi: 10.1038/s41598-025-12526-1.
2
Estimation of the value-based price of a blood test for Alzheimer's disease pathology in primary and specialty care in the U.S.美国初级和专科护理中阿尔茨海默病病理学血液检测基于价值的价格估算
J Prev Alzheimers Dis. 2025 Aug;12(7):100219. doi: 10.1016/j.tjpad.2025.100219. Epub 2025 Jun 9.
3
Dementia care management in primary care practices: a descriptive study among nurse practitioners.

本文引用的文献

1
Alzheimer's Disease: Combination Therapies and Clinical Trials for Combination Therapy Development.阿尔茨海默病:联合治疗以及用于联合治疗开发的临床试验。
CNS Drugs. 2024 Aug;38(8):613-624. doi: 10.1007/s40263-024-01103-1. Epub 2024 Jun 27.
2
Association Between Socioeconomic Factors, Race, and Use of a Specialty Memory Clinic.社会经济因素、种族与使用专业记忆门诊之间的关联。
Neurology. 2023 Oct 3;101(14):e1424-e1433. doi: 10.1212/WNL.0000000000207674. Epub 2023 Aug 2.
3
Expected and diagnosed rates of mild cognitive impairment and dementia in the U.S. Medicare population: observational analysis.
基层医疗实践中的痴呆症护理管理:执业护士的描述性研究
BMC Prim Care. 2025 May 15;26(1):164. doi: 10.1186/s12875-025-02855-5.
4
Diagnostic journey and management of patients with mild cognitive impairment and Alzheimer's disease dementia: A multinational, real-world survey.轻度认知障碍和阿尔茨海默病痴呆患者的诊断历程与管理:一项跨国真实世界调查。
J Alzheimers Dis. 2025 Apr;104(4):1212-1234. doi: 10.1177/13872877251322978. Epub 2025 Mar 20.
5
Passive Anti-amyloid Beta Monoclonal Antibodies: Lessons Learned over Past 20 Years.被动抗淀粉样β单克隆抗体:过去20年的经验教训
Neurol Ther. 2024 Dec;13(6):1571-1595. doi: 10.1007/s40120-024-00664-z. Epub 2024 Oct 8.
美国医疗保险人群中轻度认知障碍和痴呆的预期和诊断率:观察性分析。
Alzheimers Res Ther. 2023 Jul 22;15(1):128. doi: 10.1186/s13195-023-01272-z.
4
Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial.多奈哌齐治疗早期症状性阿尔茨海默病的随机临床试验。
JAMA. 2023 Aug 8;330(6):512-527. doi: 10.1001/jama.2023.13239.
5
Alzheimer's disease drug development pipeline: 2023.2023年阿尔茨海默病药物研发进展
Alzheimers Dement (N Y). 2023 May 25;9(2):e12385. doi: 10.1002/trc2.12385. eCollection 2023 Apr-Jun.
6
Designing the next-generation clinical care pathway for Alzheimer's disease.设计阿尔茨海默病的下一代临床护理路径。
Nat Aging. 2022 Aug;2(8):692-703. doi: 10.1038/s43587-022-00269-x. Epub 2022 Aug 19.
7
Expanding the use of brief cognitive assessments to detect suspected early-stage cognitive impairment in primary care.在初级保健中扩大使用简短认知评估来检测疑似早期认知障碍。
Alzheimers Dement. 2023 Sep;19(9):4252-4259. doi: 10.1002/alz.13051. Epub 2023 Apr 19.
8
Rural and urban differences in quality of dementia care of persons with dementia and caregivers across all domains: a systematic review.农村和城市在痴呆症患者和护理人员所有领域的痴呆症护理质量方面的差异:系统评价。
BMC Health Serv Res. 2023 Jan 31;23(1):102. doi: 10.1186/s12913-023-09100-8.
9
Lecanemab in Early Alzheimer's Disease.早期阿尔茨海默病中的lecanemab
N Engl J Med. 2023 Jan 5;388(1):9-21. doi: 10.1056/NEJMoa2212948. Epub 2022 Nov 29.
10
Trends in inequalities in the prevalence of dementia in the United States.美国痴呆症患病率不平等趋势。
Proc Natl Acad Sci U S A. 2022 Nov 16;119(46):e2212205119. doi: 10.1073/pnas.2212205119. Epub 2022 Nov 7.